CPC A61K 31/145 (2013.01) [G01N 33/6854 (2013.01)] | 12 Claims |
1. A method of treating renal IgA deposition in mammals, the method comprising administering a therapeutically effective amount of a thiol-containing molecule, or a pharmaceutically acceptable salt thereof, to a mammal suffering from or at risk of having IgA nephropathy, wherein the thiol-containing molecule is selected from the group consisting of cysteamine, 2-[(3-aminopropyl) amino] ethanethiol, and N-acetylcysteine.
|